PT81566A - Process for preparing amino-salicylic acid derivatives - Google Patents

Process for preparing amino-salicylic acid derivatives

Info

Publication number
PT81566A
PT81566A PT81566A PT8156685A PT81566A PT 81566 A PT81566 A PT 81566A PT 81566 A PT81566 A PT 81566A PT 8156685 A PT8156685 A PT 8156685A PT 81566 A PT81566 A PT 81566A
Authority
PT
Portugal
Prior art keywords
acid derivatives
salicylic acid
preparing amino
amino
preparing
Prior art date
Application number
PT81566A
Other languages
Portuguese (pt)
Other versions
PT81566B (en
Inventor
Giancarlo Sportoletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of PT81566A publication Critical patent/PT81566A/en
Publication of PT81566B publication Critical patent/PT81566B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT81566A 1984-11-29 1985-11-27 Process for preparing amino-salicylic acid derivatives PT81566B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23799/84A IT1196348B (en) 1984-11-29 1984-11-29 COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY

Publications (2)

Publication Number Publication Date
PT81566A true PT81566A (en) 1985-12-01
PT81566B PT81566B (en) 1987-04-07

Family

ID=11210091

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81566A PT81566B (en) 1984-11-29 1985-11-27 Process for preparing amino-salicylic acid derivatives

Country Status (12)

Country Link
EP (1) EP0236329A1 (en)
JP (1) JPS62501703A (en)
KR (1) KR870700608A (en)
CN (1) CN85109554A (en)
AU (1) AU5231186A (en)
DK (1) DK346486A (en)
ES (1) ES8701717A1 (en)
GR (1) GR852834B (en)
IT (1) IT1196348B (en)
PT (1) PT81566B (en)
WO (1) WO1986003199A1 (en)
ZA (1) ZA859035B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
GB9017711D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
IT1244873B (en) * 1990-09-12 1994-09-12 Depha Team Srl DERIVATIVES OF 5-AMINOSALICYLIC ACID (5-ASA) FOR THE THERAPY OF CHRONIC INTESTINAL INFLAMMATIONS
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
FR2738150B1 (en) * 1995-09-01 1997-10-31 Synthelabo USE OF SULPHASALAZINE AND ITS METABOLITES FOR THE MANUFACTURE OF A MEDICAMENT USEFUL IN THE TREATMENT OF VENOUS INSUFFICIENCY AND VENOUS ULCERS
EP1274675B1 (en) * 2000-04-19 2004-09-01 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
US6964982B2 (en) 2000-04-20 2005-11-15 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
DE60114724T2 (en) * 2000-07-18 2006-06-01 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Blood flow improvers and preparations for the prevention or cure of thrombosis
EP1225449B1 (en) 2001-01-19 2008-10-22 Apex Biotechnology Corporation Non-enzymatic disposable electrode strip comprising a surfactant for detecting uric acid or hemoglobin; method for producing the same and its use
BR0212510A (en) 2001-09-14 2004-08-24 Methylgene Inc Histone Deacetylase Inhibitor, Compound and Composition
JP4113957B2 (en) 2002-06-19 2008-07-09 アムコア ファーマ, インコーポレイテッド Tetrafluorobenzyl derivative and pharmaceutical composition for prevention and treatment of acute and degenerative cranial nervous system diseases containing the same
KR100668111B1 (en) 2005-07-28 2007-01-12 (주)에스에이치제약 New aminosalicylic acid analogs, it's pharmaceutically acceptable salts and their preparations
KR101333753B1 (en) * 2006-04-13 2013-11-28 주식회사 아라온테크 Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
CN100422721C (en) * 2006-05-26 2008-10-01 南京大学 Aluminium ion investigating method using glycosyl naphthol
JP5470046B2 (en) * 2007-10-23 2014-04-16 株式会社医薬分子設計研究所 PAI-1 production inhibitor
KR100852962B1 (en) 2007-11-12 2008-08-20 주식회사 뉴로테크 Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
CA2729186C (en) * 2008-07-08 2018-01-16 Catabasis Pharmaceuticals, Inc. Fatty acid acetylated salicylates and their uses
KR101204108B1 (en) * 2009-02-09 2012-11-22 주식회사 지엔티파마 Medicinal use of 5-benzylaminosalicylic acid derivative or its salt
MX2012002710A (en) 2009-09-01 2012-04-19 Catabasis Pharmaceuticals Inc Fatty acid niacin conjugates and their uses.
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
CN104603100A (en) * 2012-05-23 2015-05-06 塞利克斯比奥私人有限公司 Compositions and methods for treatment of inflammatory bowel disease
WO2014070859A1 (en) * 2012-10-30 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stat3 dimerization inhibitors
KR20210107828A (en) * 2018-12-28 2021-09-01 주식회사 지엔티파마 Compositions and methods for treating neurodegenerative diseases
CN111116395B (en) * 2019-12-27 2023-04-07 湖北工业大学 Multi-iodo aromatic acid compound and application thereof in resisting adenovirus 7

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4546M (en) * 1964-06-09 1966-11-02
NL7008623A (en) * 1969-06-25 1970-12-29
JPS5640710B2 (en) * 1973-01-18 1981-09-22
JPS6056130B2 (en) * 1978-03-20 1985-12-09 久光製薬株式会社 Novel salicylic acid derivatives
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds

Also Published As

Publication number Publication date
DK346486D0 (en) 1986-07-21
IT1196348B (en) 1988-11-16
JPS62501703A (en) 1987-07-09
ES549359A0 (en) 1986-12-01
CN85109554A (en) 1986-07-23
IT8423799A0 (en) 1984-11-29
WO1986003199A1 (en) 1986-06-05
AU5231186A (en) 1986-06-18
KR870700608A (en) 1987-12-30
DK346486A (en) 1986-07-21
ES8701717A1 (en) 1986-12-01
GR852834B (en) 1986-03-27
EP0236329A1 (en) 1987-09-16
PT81566B (en) 1987-04-07
ZA859035B (en) 1986-08-27

Similar Documents

Publication Publication Date Title
HUT37149A (en) Process for producing quinoline- and naphtiridine-carboxylic acid derivatives
HUT35639A (en) Process for preparing 3-chloro-1-formyl-4-phenyl-pyrrole derivatives
PT81566A (en) Process for preparing amino-salicylic acid derivatives
HUT41786A (en) Process for producing 1-carba-/1-dethia/-3-cepheme-4-carboxylic acid derivatives
HUT38941A (en) Process for preparing triazolo-quinazoline derivatives
HUT38093A (en) Process for preparing benzene-sulphonamide derivatives
HUT36805A (en) Process for preparing 1-cyclopropyl-quinoline- and -naphthyridine-carboxylic acid derivatives
HUT38317A (en) Process for preparing ethylene-diamino-monoamide derivatives
PT82384A (en) Process for preparing substituted 2,3,4,9-tetra-hydro-1h-carbazole-1-acetic acid derivatives
HUT38604A (en) Process for preparing fluoro-alkyl-amine derivatives
HUT40114A (en) Process for preparing flavolignane derivatives
HUT38333A (en) Process for preparing 1-piperidino-2-phenyl-quinoline derivatives
DE3565251D1 (en) Process for preparing anti-inflammatory cycloalkylidenemethylphenylacetic acid derivatives
HUT38306A (en) Process for preparing phenyl nonatetraenic acid derivatives
GB2199030B (en) Process for preparing alpha-phenylpropionic acid derivative
HUT37757A (en) Process for preparing 2-substituted-5-methyl-pyridina derivatives
RO93563B (en) Process for preparing 3-phenoxyphenyl-propane-1-il-cyclopropane derivatives
PL256014A1 (en) Process for preparing novel derivatives of 6-hydroxymethyl-penicillanic acid
HUT38912A (en) Process for producing quinolon- and naphtiridon-carboxylic acid derivatives
GB2157287B (en) Process for preparing 3-exomethylenecepham derivatives
HUT40083A (en) Process for producing quinolon-carboxylic acid derivatives
HUT36800A (en) Process for preparing carbamidic acid derivatives
HUT41767A (en) Process for producing quinolon-carboxylic acid derivatives
HUT42050A (en) Process for preparing 2-choloro-propionic acid
PT80643A (en) Process for preparing nitroethenamina derivatives